Dermavant Announces Positive Results from Phase IV Open-Label Trial of VTAMA® (tapinarof) Cream, 1% for the Treatment of Plaque Psoriasis in the Head and Neck Region in Adults

Dermavant Sciences announced positive results from its Phase IV, open-label clinical trial of VTAMA® cream, 1% for the treatment of plaque psoriasis in the head and neck region in adults.